http://www.cnr.it/ontology/cnr/individuo/unitaDiPersonaleEsterno/ID1042
MICAELA MORELLI
- Type
- Label
- MICAELA MORELLI (literal)
- MICAELA MORELLI (literal)
- Partecipa a commessa
- Persona in rapporto
- Autore CNR di
- Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independently from dopamine release (Contributo in atti di convegno) (Prodotto della ricerca)
- Alteration in the progression of dopamine neuron degeneration: May caffeine offer new perspective? (Articolo in rivista) (Prodotto della ricerca)
- Sanna E, Talani G, Obili N, Mascia MP, Mostallino MC, Secci PP, Pisu MG, Biggio F, Utzeri C, Olla P, Biggio G, Follesa P. Voluntary Ethanol Consumption Induced by Social Isolation Reverses the Increase of ±(4)/´ GABA(A) Receptor Gene Expression and Functi (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- SUBCHRONIC-INTERMITTENT CAFFEINE AMPLIFIES THE MOTOR EFFECTS OF AMPHETAMINE IN RATS (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Sensitization to caffeine and cross-sensitization to amphetamine: influence of (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Methylxanthines and drug dependence: a focus on interactions with substances of abuse (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release. (Articolo in rivista) (Prodotto della ricerca)
- Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons. (Articolo in rivista) (Prodotto della ricerca)
- Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats (Articolo in rivista) (Prodotto della ricerca)
- Increase of dopamine D2(High) receptors in the striatum of rats sensitized to caffeine motor effects (Articolo in rivista) (Prodotto della ricerca)
- Blockade of A(2A) receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulata (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Late-onset parkinsonism in NF-kB/c-Rel deficient mice (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- The 6-hydroxydopamine model of Parkinson's disease (Articolo in rivista) (Prodotto della ricerca)
- MDMA ADMINISTRATION DURING ADOLESCENCE EXACERBATES MPTP-INDUCED COGNITIVE IMPAIRMENT, NEURODEGENERATION AND NEUROINFLAMMATION IN MOTOR, LIMBIC AND CORTICAL AREAS (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Role of movement in long-term basal ganglia changes: implications for abnormal motor responses (Articolo in rivista) (Prodotto della ricerca)
- EFFICACY OF RASAGILINE ON PROGRESSIVE DOPAMINE NEURON DEGENERATION AND NEUROINFLAMMATION IN A CHRONIC MPTPP MODEL OF PARKINSON'S DISEASE (Abstract/Poster in convegno) (Prodotto della ricerca)
- Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Behavioral and biochemical characterization as antiparkinsonian drug of the new adenosine A2A antagonist 8-ethoxy-9-ethyladenine (Contributo in atti di convegno) (Prodotto della ricerca)
- ADENOSINE A2A RECEPTOR ANTAGONIST TREATMENT OF PARKINSONS DISEASE. In The basal ganglia pathophysiology: recent advances (Contributo in volume (capitolo o saggio)) (Prodotto della ricerca)
- Interaction between antagonists of adenosine A2A receptors and agonists of serotonin 5-HT1A/B receptors: a novel therapeutic strategy for the control of dyskinesia in the therapy of Parkinson's disease (Contributo in atti di convegno) (Prodotto della ricerca)
- Caffeine consumption and Changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine. Published in Advances in psychology research (Contributo in volume (capitolo o saggio)) (Prodotto della ricerca)
- MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Antagonism of adenosine A1 or A2A receptors amplifies the effects of 3,4-methylendioxymethamphetamine (MDMA) on glial activation in the mouse brain: relevance to caffeine-MDMA interactions (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- New adenosine A2A antagonist: Behavioral and Biochemical characterizations as antiparkinsonian drug (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Comparative study of the influence of the acute administration of drugs of abuse on 50-kHz (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease. (Articolo in rivista) (Prodotto della ricerca)
- Assessment of Symptomatic and Neuroprotective Efficacy of Mucuna Pruriens Seed Extract in Rodent Model of Parkinson's Disease (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Can dietary substances protect against Parkinson's disease? The case of caffeine (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: Comparison of the effects of different psychoactive drugs and relevance in drug-induced reward (Articolo in rivista) (Prodotto della ricerca)
- Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression (Articolo in rivista) (Prodotto della ricerca)
- . MODEL OF DYSKINESIA IN 6-HYDROXYDOPAMINE LESIONED RATS: VALITDITY OF SENSITIZATION IN TURNING BEHAVIOUR AND ABNORMAL INVOLUNTARY MOVEMENTS (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Behavioral, Neurochemical, and Electrophysiological Changes in an Early Spontaneous Mouse Model of Nigrostriatal Degeneration (Articolo in rivista) (Prodotto della ricerca)
- A Critical Evaluation of Behavioral Rodent Models of Motor Impairment Used for Screening of Antiparkinsonian Activity: The Case of Adenosine A(2A) Receptor Antagonists (Articolo in rivista) (Prodotto della ricerca)
- REPEATED INTERMITTENT CAFFEINE POTENTIATES AMPHETAMINE-MEDIATED MOTOR STIMULANT EFFECTS AND ZIF-268 MRNA EXPRESSION IN STRIATONIGRAL NEURONS (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- RECEPTOR ANTAGONISTS IMPROVE AKINESIA AND SENSORY-MOTOR DEFICITS IN THE 6-HYDROXYDOPAMINE MODEL OF PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Expression of dyskinetic movements and turning behaviour in subchronic L-DOPA 6-hydroxydopamine-treated rats is influenced by the testing environment (Articolo in rivista) (Prodotto della ricerca)
- A new ethyladenine antagonist of adenosine A(2A) receptors: behavioural and biochemical characterization as an antiparkinsonian drug (Articolo in rivista) (Prodotto della ricerca)
- . Interaction between metabotropic adenosina A2A and glutamate MGLU5 receptors in parkinsonian-like muscle rigidity and tremor (Contributo in atti di convegno) (Prodotto della ricerca)
- SENSITIZATION TO TURNING BEHAVIOUR AND ABNORMAL INVOLUNTARY MOVEMENTS IN 6-HYDROXYDOPAMINE LESIONED RATS: INHFLUENCE OF THE ENVIRONMENT IN WHICH TESTS ARE PERFORMED (Contributo in atti di convegno) (Prodotto della ricerca)
- Adenosine A(2A) receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease. (Articolo in rivista) (Prodotto della ricerca)
- ADENOSINE A2A ANTAGONISTS AND PARKINSONS DISEASE: NEW FINDINGS ON PARKINSONIAN TREMOR (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- MODULATORY ROLE OF ADENOSINE A2A RECEPTORS AS BASIS FOR THE USE OF A2A ANTAGONISTS IN THE TREATMENT OF PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- LOCALIZING ANTIPARKINSONIAN MECHANISMS OF A2A RECEPTOR ANTAGONISTS IN BASAL GANGLIA (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Involvement of globus pallidus in the antiparkinsonian effects of adenosine A(2A)receptor antagonists (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- ADENOSINE A2A RECEPTOR ANTAGONISTS IN THE THERAPY OF PARKINSON'S DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- M. Morelli, N. Simola, A. Pinna, S. Pontis (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- CHRONIC INTERMITTENT TREATMENT WITH L-DOPA DIFFERENTIALLY AFFECTS ZIF268 AND GAD67 mRNA EXPRESSION IN DIRECT AND INDIRECT STRIATAL EFFERENT PATHWAYS. (Contributo in atti di convegno) (Prodotto della ricerca)
- Symptomatic efficacy of mucuna pruriens seed extract in rodent model of Parkinsons disease (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Behavioural and biochemical characterization of c-Rel mutant mice as model of Parkinsons diseas (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- ALTERED RESPONSE OF STRIATAL AND PALLIDAL NEURONS AND UNBALANCED MODULATION OF SUBSTANTIA NIGRA RETICULATA ACTIVITY MAY UNDERLIE ABNORMAL MOVEMENTS IN SUBCHRONICALLY L-DOPA TREATED RATS. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- CAFFEINE SENSITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST BUT NOT PRE-SYNAPTIC CHANGES IN RAT STRIATAL NEURONS. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- How reliable is the behavioural evaluation of dyskinesia in animal models of Parkinson's disease? (Articolo in rivista) (Prodotto della ricerca)
- New adenosine A2A receptor antagonists: actions on Parkinson's disease models (Articolo in rivista) (Prodotto della ricerca)
- ATTENUATION OF MPTP-INDUCED NEURODEGENERATION BY NCX 2216, A NITRIC OXIDE-RELEASING DERIVATIVE OF FLURBIPROFEN (Contributo in atti di convegno) (Prodotto della ricerca)
- Receptor Antagonism and Dyskinesia in Parkinson's Disease (Articolo in rivista) (Prodotto della ricerca)
- Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: implications for the study of the affective properties of drugs of abuse (Articolo in rivista) (Prodotto della ricerca)
- LATE-ONSET PARKINSONISM AND PREMOTOR PATHOLOGY IN NF-KB/C-REL-DEFICIENT MICE (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- FARMACI ANTIPARKINSONIANI ED ATTIVI IN ALTRI DISTURBI MOTORI, vol. 30 del Trattato di Farmacologia (Contributo in volume (capitolo o saggio)) (Prodotto della ricerca)
- Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence. (Articolo in rivista) (Prodotto della ricerca)
- Caffeine enhances astroglia and microglia reactivity induced by 3,4-methylenedioxymethamphetamine ('Ecstasy') in mouse brain. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in adolescent mice chronically treated with 3,4-methylenedioxymethamphetamine (MDMA) (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease (Articolo in rivista) (Prodotto della ricerca)
- Priming of rotational behavior by a dopamine receptor agonist in Hemiparkinsonian rats: movement-dependent induction (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- A new therapeutic strategy for Parkinson's disease (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA pretreated mice (Articolo in rivista) (Prodotto della ricerca)
- Novel therapeutic strategy for the control of dyskinesia in the therapy of Parkinson's disease (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Characterization of the antiparkinsonian effects of the new adenosine A(2A) receptor antagonist ST1535: Acute and subchronic studies in rats. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment (Articolo in rivista) (Prodotto della ricerca)
- Adenosine A(2A) receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats (Articolo in rivista) (Prodotto della ricerca)
- Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists (Articolo in rivista) (Prodotto della ricerca)
- Caffeine enhances astroglia and microglia reactivity induced by 3,4-methylenedioxymethamphetamine ('Ecstasy') in mouse brain (Articolo in rivista) (Prodotto della ricerca)
- Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat (Articolo in rivista) (Prodotto della ricerca)
- Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions (Articolo in rivista) (Prodotto della ricerca)
- Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D1 but not D2 receptor agonists (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Coautore
- Nome
- Cognome
- Afferisce a
- Ha pubblicazioni con
Incoming links:
- Autore CNR
- ADENOSINE A2A ANTAGONISTS AND PARKINSONS DISEASE: NEW FINDINGS ON PARKINSONIAN TREMOR (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- ADENOSINE A2A RECEPTOR ANTAGONISTS IN THE THERAPY OF PARKINSON'S DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- MODULATORY ROLE OF ADENOSINE A2A RECEPTORS AS BASIS FOR THE USE OF A2A ANTAGONISTS IN THE TREATMENT OF PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- . MODEL OF DYSKINESIA IN 6-HYDROXYDOPAMINE LESIONED RATS: VALITDITY OF SENSITIZATION IN TURNING BEHAVIOUR AND ABNORMAL INVOLUNTARY MOVEMENTS (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- REPEATED INTERMITTENT CAFFEINE POTENTIATES AMPHETAMINE-MEDIATED MOTOR STIMULANT EFFECTS AND ZIF-268 MRNA EXPRESSION IN STRIATONIGRAL NEURONS (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- RECEPTOR ANTAGONISTS IMPROVE AKINESIA AND SENSORY-MOTOR DEFICITS IN THE 6-HYDROXYDOPAMINE MODEL OF PARKINSONS DISEASE (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- ATTENUATION OF MPTP-INDUCED NEURODEGENERATION BY NCX 2216, A NITRIC OXIDE-RELEASING DERIVATIVE OF FLURBIPROFEN (Contributo in atti di convegno) (Prodotto della ricerca)
- LOCALIZING ANTIPARKINSONIAN MECHANISMS OF A2A RECEPTOR ANTAGONISTS IN BASAL GANGLIA (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- M. Morelli, N. Simola, A. Pinna, S. Pontis (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Symptomatic efficacy of mucuna pruriens seed extract in rodent model of Parkinsons disease (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Behavioural and biochemical characterization of c-Rel mutant mice as model of Parkinsons diseas (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- Adenosine A(2A) receptor antagonism increases striatal glutamate outflow in dopamine-denervated rats (Articolo in rivista) (Prodotto della ricerca)
- New adenosine A2A receptor antagonists: actions on Parkinson's disease models (Articolo in rivista) (Prodotto della ricerca)
- Blockade of A(2A) receptors plus L-DOPA after nigrostriatal lesion results in GAD67 mRNA changes different from L-DOPA alone in the rat globus pallidus and substantia nigra reticulata (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independent from dopamine release. (Articolo in rivista) (Prodotto della ricerca)
- Subchronic intermittent caffeine administration to unilaterally 6-hydroxydopamine-lesioned rats sensitizes turning behaviour in response to dopamine D1 but not D2 receptor agonists (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- How reliable is the behavioural evaluation of dyskinesia in animal models of Parkinson's disease? (Articolo in rivista) (Prodotto della ricerca)
- Expression of dyskinetic movements and turning behaviour in subchronic L-DOPA 6-hydroxydopamine-treated rats is influenced by the testing environment (Articolo in rivista) (Prodotto della ricerca)
- Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat (Articolo in rivista) (Prodotto della ricerca)
- Adenosine A2A receptor antagonists and Parkinson's disease: state of the art and future directions (Articolo in rivista) (Prodotto della ricerca)
- Potentiation of amphetamine-mediated responses in caffeine-sensitized rats involves modifications in A2A receptors and zif-268 mRNAs in striatal neurons (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Blockade of globus pallidus adenosine A(2A) receptors displays antiparkinsonian activity in 6-hydroxydopamine-lesioned rats treated with D(1) or D(2) dopamine receptor agonists (Articolo in rivista) (Prodotto della ricerca)
- Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease (Articolo in rivista) (Prodotto della ricerca)
- Priming of rotational behavior by a dopamine receptor agonist in Hemiparkinsonian rats: movement-dependent induction (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Adenosine A2A and dopamine receptor interactions in basal ganglia of dopamine denervated rats. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- New therapies for the treatment of Parkinson's disease: adenosine A2A receptor antagonists (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Characterization of the antiparkinsonian effects of the new adenosine A(2A) receptor antagonist ST1535: Acute and subchronic studies in rats. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Direct and indirect striatal efferent pathways are differentially influenced by low and high dyskinetic drugs: behavioural and biochemical evidence. (Articolo in rivista) (Prodotto della ricerca)
- Adenosine A(2A) receptor antagonists improve deficits in initiation of movement and sensory motor integration in the unilateral 6-hydroxydopamine rat model of Parkinson's disease. (Articolo in rivista) (Prodotto della ricerca)
- The 6-hydroxydopamine model of Parkinson's disease (Articolo in rivista) (Prodotto della ricerca)
- Acute perinatal asphyxia impairs non-spatial memory and alters motor coordination in adult male rats (Articolo in rivista) (Prodotto della ricerca)
- Increase of dopamine D2(High) receptors in the striatum of rats sensitized to caffeine motor effects (Articolo in rivista) (Prodotto della ricerca)
- Sensitization to caffeine and cross-sensitization to amphetamine: influence of (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Caffeine enhances astroglia and microglia reactivity induced by 3,4-methylenedioxymethamphetamine ('Ecstasy') in mouse brain (Articolo in rivista) (Prodotto della ricerca)
- Can dietary substances protect against Parkinson's disease? The case of caffeine (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Involvement of globus pallidus in the antiparkinsonian effects of adenosine A(2A)receptor antagonists (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Dyskinetic potential of dopamine agonists is associated with different striatonigral/striatopallidal zif-268 expression (Articolo in rivista) (Prodotto della ricerca)
- Behavioral, Neurochemical, and Electrophysiological Changes in an Early Spontaneous Mouse Model of Nigrostriatal Degeneration (Articolo in rivista) (Prodotto della ricerca)
- Methylxanthines and drug dependence: a focus on interactions with substances of abuse (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Sanna E, Talani G, Obili N, Mascia MP, Mostallino MC, Secci PP, Pisu MG, Biggio F, Utzeri C, Olla P, Biggio G, Follesa P. Voluntary Ethanol Consumption Induced by Social Isolation Reverses the Increase of ±(4)/´ GABA(A) Receptor Gene Expression and Functi (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease. (Articolo in rivista) (Prodotto della ricerca)
- Subchronic caffeine exposure induces sensitization to caffeine and cross-sensitization to amphetamine ipsilateral turning behavior independently from dopamine release (Contributo in atti di convegno) (Prodotto della ricerca)
- CHRONIC INTERMITTENT TREATMENT WITH L-DOPA DIFFERENTIALLY AFFECTS ZIF268 AND GAD67 mRNA EXPRESSION IN DIRECT AND INDIRECT STRIATAL EFFERENT PATHWAYS. (Contributo in atti di convegno) (Prodotto della ricerca)
- CAFFEINE SENSITIZATION AND CROSS-SENSITIZATION WITH AMPHETAMINE: ASSOCIATION TO POST BUT NOT PRE-SYNAPTIC CHANGES IN RAT STRIATAL NEURONS. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- ALTERED RESPONSE OF STRIATAL AND PALLIDAL NEURONS AND UNBALANCED MODULATION OF SUBSTANTIA NIGRA RETICULATA ACTIVITY MAY UNDERLIE ABNORMAL MOVEMENTS IN SUBCHRONICALLY L-DOPA TREATED RATS. (Contributo in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1301)
- . Interaction between metabotropic adenosina A2A and glutamate MGLU5 receptors in parkinsonian-like muscle rigidity and tremor (Contributo in atti di convegno) (Prodotto della ricerca)
- SENSITIZATION TO TURNING BEHAVIOUR AND ABNORMAL INVOLUNTARY MOVEMENTS IN 6-HYDROXYDOPAMINE LESIONED RATS: INHFLUENCE OF THE ENVIRONMENT IN WHICH TESTS ARE PERFORMED (Contributo in atti di convegno) (Prodotto della ricerca)
- New adenosine A2A antagonist: Behavioral and Biochemical characterizations as antiparkinsonian drug (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- ADENOSINE A2A RECEPTOR ANTAGONIST TREATMENT OF PARKINSONS DISEASE. In The basal ganglia pathophysiology: recent advances (Contributo in volume (capitolo o saggio)) (Prodotto della ricerca)
- Caffeine consumption and Changes in the function of dopaminergic transmission: evidence of a hyperdopaminergic state in rats subchronically treated with caffeine. Published in Advances in psychology research (Contributo in volume (capitolo o saggio)) (Prodotto della ricerca)
- FARMACI ANTIPARKINSONIANI ED ATTIVI IN ALTRI DISTURBI MOTORI, vol. 30 del Trattato di Farmacologia (Contributo in volume (capitolo o saggio)) (Prodotto della ricerca)
- A new ethyladenine antagonist of adenosine A(2A) receptors: behavioural and biochemical characterization as an antiparkinsonian drug (Articolo in rivista) (Prodotto della ricerca)
- Pharmacological characterization of 50-kHz ultrasonic vocalizations in rats: Comparison of the effects of different psychoactive drugs and relevance in drug-induced reward (Articolo in rivista) (Prodotto della ricerca)
- Different responsiveness of striatonigral and striatopallidal neurons to L-DOPA after a subchronic intermittent L-DOPA treatment (Articolo in rivista) (Prodotto della ricerca)
- Assessment of Symptomatic and Neuroprotective Efficacy of Mucuna Pruriens Seed Extract in Rodent Model of Parkinson's Disease (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Caffeine enhances astroglia and microglia reactivity induced by 3,4-methylenedioxymethamphetamine ('Ecstasy') in mouse brain. (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Alteration in the progression of dopamine neuron degeneration: May caffeine offer new perspective? (Articolo in rivista) (Prodotto della ricerca)
- Performance of movement in hemiparkinsonian rats influences the modifications induced by dopamine agonists in striatal efferent dynorphinergic neurons. (Articolo in rivista) (Prodotto della ricerca)
- MPTP-induced dopamine neuron degeneration and glia activation is potentiated in MDMA pretreated mice (Articolo in rivista) (Prodotto della ricerca)
- Receptor Antagonism and Dyskinesia in Parkinson's Disease (Articolo in rivista) (Prodotto della ricerca)
- SUBCHRONIC-INTERMITTENT CAFFEINE AMPLIFIES THE MOTOR EFFECTS OF AMPHETAMINE IN RATS (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Role of movement in long-term basal ganglia changes: implications for abnormal motor responses (Articolo in rivista) (Prodotto della ricerca)
- Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Direct and long-lasting effects elicited by repeated drug administration on 50-kHz ultrasonic vocalizations are regulated differently: implications for the study of the affective properties of drugs of abuse (Articolo in rivista) (Prodotto della ricerca)
- Vulnerability to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) toxicity in adolescent mice chronically treated with 3,4-methylenedioxymethamphetamine (MDMA) (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- A new therapeutic strategy for Parkinson's disease (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Novel therapeutic strategy for the control of dyskinesia in the therapy of Parkinson's disease (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- LATE-ONSET PARKINSONISM AND PREMOTOR PATHOLOGY IN NF-KB/C-REL-DEFICIENT MICE (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Dyskinesia in Parkinson's disease: mechanisms and current non-pharmacological interventions (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- Antagonism of adenosine A1 or A2A receptors amplifies the effects of 3,4-methylendioxymethamphetamine (MDMA) on glial activation in the mouse brain: relevance to caffeine-MDMA interactions (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)
- A Critical Evaluation of Behavioral Rodent Models of Motor Impairment Used for Screening of Antiparkinsonian Activity: The Case of Adenosine A(2A) Receptor Antagonists (Articolo in rivista) (Prodotto della ricerca)
- Late-onset parkinsonism in NF-kB/c-Rel deficient mice (Abstract/Poster in atti di convegno) (Prodotto della ricerca)
- MDMA ADMINISTRATION DURING ADOLESCENCE EXACERBATES MPTP-INDUCED COGNITIVE IMPAIRMENT, NEURODEGENERATION AND NEUROINFLAMMATION IN MOTOR, LIMBIC AND CORTICAL AREAS (Abstract/Poster in convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1304)
- Comparative study of the influence of the acute administration of drugs of abuse on 50-kHz (Abstract/Poster in atti di convegno) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1302)
- Interaction between antagonists of adenosine A2A receptors and agonists of serotonin 5-HT1A/B receptors: a novel therapeutic strategy for the control of dyskinesia in the therapy of Parkinson's disease (Contributo in atti di convegno) (Prodotto della ricerca)
- EFFICACY OF RASAGILINE ON PROGRESSIVE DOPAMINE NEURON DEGENERATION AND NEUROINFLAMMATION IN A CHRONIC MPTPP MODEL OF PARKINSON'S DISEASE (Abstract/Poster in convegno) (Prodotto della ricerca)
- Behavioral and biochemical characterization as antiparkinsonian drug of the new adenosine A2A antagonist 8-ethoxy-9-ethyladenine (Contributo in atti di convegno) (Prodotto della ricerca)
- Coautore
- Ha pubblicazioni con
- Ha afferente
- Partecipazione di
- Rapporto con persona